News | September 25, 2013

Study Assesses Use of Fingerstick Blood Sample With i-STAT Point-of-Care Troponin Test Device

Venipuncture still the gold standard in cardiac care

Loyola, Loyola Health, Loyola Medical Center

September 25, 2013 — Researchers have determined that fingerstick cardiac troponin I assay testing using the point-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term.

The study was funded by the department of emergency medicine, Loyola University Medical Center and was published in the American Journal of Emergency Medicine. The study was conducted by Devin Loewenstein, BS, Christine Stake, MA and Mark Cichon, DO of Loyola University Chicago, department of emergency medicine.

“Cardiac troponin assays commonly exceed one hour while point-of-care testing can be completed in minutes by basic life support personnel,” said Cichon, who is chair of the emergency medicine department at Loyola. “When patients present complaining of chest pain, time can be critical to achieving positive outcomes, so Loyola was very keen to test this timesaving process.” Currently Loyola is the only academic medical center in Chicago to utilize the i-STAT device.

Conducted in the Loyola Level 1 trauma center emergency department from June to August 2011, fingerstick blood samples were collected from consenting patients for whom standard-of-care venipuncture POC troponin (POCT) testing had been ordered as part of their workup. Cardiac tropnin (cTnl) assays were performed using the i-STAT I device.

Eighty-nine cTnl levels were measured by both fingerstick and standard venipuncture. “While fingerstick testing was not accurate enough to solely determine the exact troponin level, it is accurate in qualifying tropnonin levels as negative, borderline or positive which is clinical information that may guide critical decision making,” said Cichon, who is on the board of directors of the Illinois College of Emergency Physicians (ICEP).

Cichon has served as division director for Loyola Emergency Medicine for the past 16 years. He has instituted several innovative programs to improve care for critically ill patients, including the heart attack rapid response team, telemedicine stroke program, sepsis blood infection program and hypothermia program.

For more information:

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing | May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing | April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing | April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing | April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing | March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing | January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing | July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing | March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init